These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4809445)

  • 1. Contrasting effect of hemodialysis and peritoneal dialysis on the inhibition of in vitro calcification by uremic serum.
    Oreopoulos DG; Pitel S; Husdan H; de Veber GA; Rapoport A
    Can Med Assoc J; 1974 Jan; 110(1):43-7. PubMed ID: 4809445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
    Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
    Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
    [No Abstract]   [Full Text] [Related]  

  • 3. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone.
    Arieff AI; Massry SG
    J Clin Invest; 1974 Feb; 53(2):387-92. PubMed ID: 11344551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
    Epstein S; Traberg H; Raja R; Poser J
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
    Kario K; Matsuo T; Yamada T; Matsuo M
    Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
    Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
    Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace elements in patients on chronic hemodialysis. 2. Plasma magnesium.
    Shirai T; Imori H; Konomi G; Nakao M; Minoda H; Ikuta T
    Fukuoka Shika Daigaku Gakkai Zasshi; 1989; 16(1):11-8. PubMed ID: 2632286
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electroencephalographic background activity and blood biochemistry data in patients with chronic renal failure during chronic hemodialysis].
    Onozawa Y; Iwahashi K; Yoshimoto K; Munekata S; Yoshihara E; Aoki J; Kanoh Y; Akahoshi T
    Rinsho Byori; 2010 Dec; 58(12):1169-75. PubMed ID: 21348236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of end-stage renal disease and dialysis modalities on blood ammonia level.
    Vaziri ND; Khazaeli M; Nunes ACF; Harley KT; Said H; Alipour O; Lau WL; Pahl MV
    Hemodial Int; 2017 Jul; 21(3):343-347. PubMed ID: 27804262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and phosphorus metabolism and bone disease in uremia.
    Kleeman CR; Massry SG; Coburn JW; Popovtzer MM
    Clin Orthop Relat Res; 1970; 68():210-37. PubMed ID: 4905786
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessment of nutrition in dialysis patients and chronic uremic patients].
    Liu H; Duan X; Li G
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):727-30. PubMed ID: 10451942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the membrane transport of folates by anions retained in uremia.
    Jennette JC; Goldman ID
    J Lab Clin Med; 1975 Nov; 86(5):834-43. PubMed ID: 1185041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levels erythrocyte and plasma magnesium in patients in chronic dialysis].
    García-Ortiz R; Milovic I; Uribe C; Gómez M
    Rev Med Chil; 1989 May; 117(5):544-8. PubMed ID: 2519816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
    Trznadel K; Walasek L; Kidawa Z; Lutz W
    Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro calcification of rachitic rat cartilage in normal and pathological human sera with some observations on the pathogenesis of renal rickets.
    YENDT ER; CONNOR TB; HOWARD JE
    Bull Johns Hopkins Hosp; 1955 Jan; 96(1):1-19. PubMed ID: 13230696
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophysiological studies on uremic patients-comparison of peritoneal dialysis and hemodialysis.
    Hughes JR; Roxe DM; del Greco F; Krumlovsky F; Ghantous W; Ivanovich P; Quintanilla A; Salkin M; Stone N; Reins M
    Clin Electroencephalogr; 1980 Apr; 11(2):73-82. PubMed ID: 7389152
    [No Abstract]   [Full Text] [Related]  

  • 19. Excretion of inhibitors of calcification in urine Part II. Findings in patients with chronic renal failure.
    Oreopoulos DG; Walker D; Akriotis DJ; Roncari DA; Husdan H; Symvoulidis A; Deveber GA; Rapoport A; Reid DB
    Can Med Assoc J; 1975 Apr; 112(7):832-4. PubMed ID: 1168092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variations in prolactinemia in 26 uremic subjects treated by periodic hemodialysis].
    Deambrogio P; Vanni M; Aleo AG
    Minerva Med; 1985 Apr; 76(17-18):847-9. PubMed ID: 4000528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.